Atlas Trials

Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer

Clinical trial NCT00574366 · COMPLETED

Trial details

NCT number
NCT00574366
Sponsor
Vanderbilt-Ingram Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2005-12-01
Primary completion
2009-01-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.